Uncharacterized protein C18orf8
Uncharacterized protein C18orf8 (501-509) is a synthetic peptide fragment corresponding to amino acid residues 501 to 509 of the human C18orf8 protein. As a segment derived from a larger, yet functionally uncharacterized protein, this peptide serves as a valuable molecular tool for investigating the structure, function, and potential interactions of C18orf8 within various biological contexts. The sequence specificity and defined length of this peptide make it particularly suitable for targeted research applications, enabling scientists to dissect the biological roles of the parent protein at a finer resolution. Its relevance is underscored in studies aiming to elucidate the molecular mechanisms underlying uncharacterized open reading frames, which represent a significant frontier in functional genomics and proteomics.
Epitope mapping: The peptide fragment is frequently utilized in epitope mapping experiments to identify antibody binding sites within the C18orf8 protein. By presenting a defined linear sequence, researchers can assess the specificity and affinity of antibodies raised against the full-length protein or related regions. This approach supports the development and validation of immunological reagents, such as monoclonal or polyclonal antibodies, which are essential for probing protein localization, quantification, and interaction networks in cellular and biochemical assays.
Protein-protein interaction studies: As a representative sequence of the C18orf8 protein, the peptide is instrumental in characterizing potential binding partners through in vitro assays such as pull-downs, surface plasmon resonance, or peptide array screens. By immobilizing the peptide or incorporating it into binding assays, researchers can systematically investigate direct interactions with other proteins, small molecules, or macromolecular complexes, thereby shedding light on the functional connectivity and regulatory roles of the parent protein within the cell.
Post-translational modification analysis: The defined sequence of the peptide allows for precise investigation of potential post-translational modifications (PTMs) that may occur within this region of C18orf8. Researchers can utilize the peptide as a substrate in enzymatic assays to assess the addition of modifications such as phosphorylation, acetylation, or methylation. This facilitates the identification of modification sites and the study of their impact on protein function, stability, or cellular localization, contributing to a deeper understanding of regulatory mechanisms at the molecular level.
Mass spectrometry calibration and assay development: Synthetic peptides like this one play a pivotal role in the calibration and validation of mass spectrometry-based proteomic analyses. The unique sequence enables its use as a standard for method development, instrument calibration, and quantitative analyses targeting the C18orf8 protein. Incorporating the peptide into workflows enhances the sensitivity and specificity of detection, supporting accurate identification and quantification of endogenous peptides in complex biological samples.
Functional assays and structural studies: The availability of a well-defined peptide fragment enables its application in functional assays designed to probe the biological activity of the corresponding region within C18orf8. Researchers may employ the peptide in cellular uptake studies, competitive inhibition assays, or structural analyses using techniques such as circular dichroism or NMR spectroscopy. These applications provide insight into the conformational properties, binding affinities, and potential functional motifs embedded within this segment, advancing the broader understanding of uncharacterized protein families and their physiological significance.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More